AplaGen GmbH And Lonza Ltd. Have Signed A Licensing Agreement For AplaGen's CFPS-Technology (Correctly Folded Peptide Synthesis)

Lonza Ltd, Switzerland, and AplaGen, Germany closed a combined cooperation and licensing agreement for AplaGen’s “CFPS”-Technology (correctly folded peptide synthesis), a new and emerging method for the synthesis of longer mer peptides and proteins. Today peptides and proteins are required by the worldwide market as rather longer-chained products. Especially in the solid phase peptide synthesis, folding and refolding of the candidates gain higher importance. Additionally the young CFPS-technology provides certain advantages during rapid purification on large scale.

Back to news